[KLCC] QoQ TTM Result on 30-Jun-2023 [#2]

Stock
[KLCC] KLCC PROP&REITS-STAPLED SEC
Announcement Date
14-Aug-2023
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2023
Quarter
30-Jun-2023 [#2]
Profit Trend
QoQ- 1.95%
YoY- 53.56%
Quarter Report
Latest QR
Upcoming QR
KLCC's Result
KLCC's Financial Summary
View:
Show?
TTM Result
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Revenue 1,647,320 1,619,163 1,589,789 1,562,610 1,518,283 1,459,251 1,394,166 11.75%
PBT 1,202,775 1,187,423 1,076,633 1,070,339 1,053,177 1,018,880 723,265 40.32%
Tax -124,967 -121,041 -108,118 -110,988 -113,734 -107,325 -70,273 46.73%
NP 1,077,808 1,066,382 968,515 959,351 939,443 911,555 652,992 39.62%
-
NP to SH 938,767 931,294 826,167 817,417 801,789 782,664 573,525 38.84%
-
Tax Rate 10.39% 10.19% 10.04% 10.37% 10.80% 10.53% 9.72% -
Total Cost 569,512 552,781 621,274 603,259 578,840 547,696 741,174 -16.09%
-
Net Worth 13,269,197 13,341,411 13,106,718 13,088,664 13,052,558 13,124,771 12,998,397 1.38%
Dividend
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Div 740,186 731,159 723,938 709,495 695,053 686,026 660,751 7.85%
Div Payout % 78.85% 78.51% 87.63% 86.80% 86.69% 87.65% 115.21% -
Equity
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Net Worth 13,269,197 13,341,411 13,106,718 13,088,664 13,052,558 13,124,771 12,998,397 1.38%
NOSH 1,805,333 1,805,333 1,805,333 1,805,333 1,805,333 1,805,333 1,805,333 0.00%
Ratio Analysis
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
NP Margin 65.43% 65.86% 60.92% 61.39% 61.88% 62.47% 46.84% -
ROE 7.07% 6.98% 6.30% 6.25% 6.14% 5.96% 4.41% -
Per Share
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
RPS 91.25 89.69 88.06 86.56 84.10 80.83 77.22 11.76%
EPS 52.00 51.59 45.76 45.28 44.41 43.35 31.77 38.84%
DPS 41.00 40.50 40.10 39.30 38.50 38.00 36.60 7.85%
NAPS 7.35 7.39 7.26 7.25 7.23 7.27 7.20 1.38%
Adjusted Per Share Value based on latest NOSH - 1,805,333
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
RPS 91.25 89.69 88.06 86.56 84.10 80.83 77.22 11.76%
EPS 52.00 51.59 45.76 45.28 44.41 43.35 31.77 38.84%
DPS 41.00 40.50 40.10 39.30 38.50 38.00 36.60 7.85%
NAPS 7.35 7.39 7.26 7.25 7.23 7.27 7.20 1.38%
Price Multiplier on Financial Quarter End Date
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Date 29/03/24 29/12/23 29/09/23 30/06/23 31/03/23 30/12/22 30/09/22 -
Price 7.46 7.09 6.80 6.99 6.85 6.71 6.59 -
P/RPS 8.18 7.91 7.72 8.08 8.15 8.30 8.53 -2.75%
P/EPS 14.35 13.74 14.86 15.44 15.42 15.48 20.74 -21.75%
EY 6.97 7.28 6.73 6.48 6.48 6.46 4.82 27.84%
DY 5.50 5.71 5.90 5.62 5.62 5.66 5.55 -0.60%
P/NAPS 1.01 0.96 0.94 0.96 0.95 0.92 0.92 6.41%
Price Multiplier on Announcement Date
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Date 23/05/24 07/02/24 28/11/23 14/08/23 29/05/23 31/01/23 10/11/22 -
Price 7.54 7.31 6.95 6.77 6.96 7.05 6.80 -
P/RPS 8.26 8.15 7.89 7.82 8.28 8.72 8.81 -4.20%
P/EPS 14.50 14.17 15.19 14.95 15.67 16.26 21.40 -22.83%
EY 6.90 7.06 6.58 6.69 6.38 6.15 4.67 29.69%
DY 5.44 5.54 5.77 5.81 5.53 5.39 5.38 0.74%
P/NAPS 1.03 0.99 0.96 0.93 0.96 0.97 0.94 6.27%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment